You have 9 free searches left this month | for more free features.

posttransplant cyclophosphamide

Showing 1 - 25 of 1,955

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Graft Vs Host Disease, Hematopoietic Tumor Trial in Brazil (Methotrexate Injectable Solution)

Recruiting
  • Graft Vs Host Disease
  • Hematopoietic Neoplasm
  • Methotrexate Injectable Solution
  • Rio De Janeiro, RJ, Brazil
  • +3 more
Sep 10, 2021

Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, Small Lymphocytic Lymphoma Trial in Baltimore (Fludarabine,

Completed
  • Myelodysplastic Syndrome
  • +13 more
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Nov 2, 2022

Posttransplant Lymphoproliferative Disorder Trial in Germany (Rituximab sc, Rituximab sc consolidation, Rituximab sc combined

Completed
  • Posttransplant Lymphoproliferative Disorder
  • Rituximab sc
  • +3 more
  • Aachen, Germany
  • +17 more
Aug 22, 2022

Haploidentical Hematopoietic Stem Cell Transplantation Trial in Seoul (ATG-LDPTCy)

Recruiting
  • Haploidentical Hematopoietic Stem Cell Transplantation
  • Seoul, Korea, Republic of
    Samsung Medical Center
Sep 11, 2023

Leukemia, Acute, MDS, Myelomonocytic Leukemia, Chronic Trial (Itacitinib)

Not yet recruiting
  • Leukemia, Acute
  • +7 more
  • (no location specified)
Apr 10, 2023

Acute Lymphoblastic Leukemia, Myeloblastic Leukemia, Biphenotypic Acute Leukemia Trial (GVHD prevention: post-transplantation

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +5 more
  • GVHD prevention: post-transplantation cyclophosphamide, abatacept, vedolizumab, calcineurin inhibitor
  • (no location specified)
Aug 23, 2022

Acute Leukemia Trial in Suzhou (mitoxantrone liposome, ATG)

Recruiting
  • Acute Leukemia
  • mitoxantrone liposome
  • ATG
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Feb 13, 2023

Sickle Cell Disease, Thalassemia, Stem Cell Transplantation Trial run by the National Heart, Lung, and Blood Institute (NHLBI)

Recruiting
  • Sickle Cell Disease
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

Hematopoietic Stem Cell Transplantation, Multiple Myeloma Trial in Spain (Ixazomib, Tacrolimus, Sirolimus)

Recruiting
  • Hematopoietic Stem Cell Transplantation
  • Multiple Myeloma
  • Badalona, Spain
  • +7 more
May 20, 2022

GATA2, Immunodeficiency, MDS Trial run by the National Cancer Institute (NCI) (procedure, drug, biological)

Recruiting
  • GATA2
  • +2 more
  • Allogeneic HSCT
  • +8 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 18, 2022

Urinary Tract Infections, Transplant-Related Disorder Trial in Tehran (Phage)

Recruiting
  • Urinary Tract Infections
  • Transplant-Related Disorder
  • Phage
  • Tehran, Iran, Islamic Republic of
    Nooshin Dalili
Jul 21, 2023

T-Cell Peripheral Lymphoma, Gamma Delta Hepatosplenic T-Cell Lymphoma, Subcutaneous Panniculitis-Like T-Cell Lymphoma Trial run

Completed
  • T-Cell Peripheral Lymphoma
  • +3 more
  • Rituximab
  • +6 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 28, 2021

Sickle Cell Anemia Trial run by the NHLBI (PBSC Transplant, Alemtuzumab, Sirolimus)

Active, not recruiting
  • Sickle Cell Anemia
  • PBSC Transplant
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 13, 2022

Advanced Melanoma Trial in Basel (Combination of TIL Transfer with anti-PD-1 Therapy and low dose IL-2)

Recruiting
  • Advanced Melanoma
  • Combination of TIL Transfer with anti-PD-1 Therapy and low dose IL-2
  • Basel, Switzerland
    Division of Medical Oncology and Cancer Immunology, University H
Aug 3, 2021

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Trial

Recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Sep 20, 2023

Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, Chronic Myeloid Leukemia Trial in Lebanon (drug, radiation, procedure)

Recruiting
  • Acute Myeloid Leukemia
  • +8 more
  • Lebanon, New Hampshire
    Dartmouth Hitchcock Medical Center, Norris Cotton Cancer Center
Apr 29, 2021

Neuroblastoma Trial in Canada, United States (Sorafenib, Cyclophosphamide, Topotecan)

Active, not recruiting
  • Neuroblastoma
  • Los Angeles, California
  • +11 more
Jan 30, 2023

Neuroblastoma Trial in Australia, Canada, United States (DFMO, Celecoxib, Cyclophosphamide)

Active, not recruiting
  • Neuroblastoma
  • Los Angeles, California
  • +12 more
Jan 30, 2023

Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Biphenotypic Acute Leukemia Trial in Minneapolis (biological, drug,

Not yet recruiting
  • Acute Myelogenous Leukemia
  • +17 more
  • Peripheral Blood Stem Cell Transplant
  • +7 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Mar 27, 2023

Influence of Timing PTCy in AlloSCT

Not yet recruiting
  • Cyclophosphamide Toxicity
  • Allogenic Haematopoetic Transplantation
  • (no location specified)
Jun 6, 2023

Breast Cancer Trial in Shanghai (Pegylated liposomal doxorubicin, Epirubicin, Cyclophosphamid)

Recruiting
  • Breast Cancer
  • Pegylated liposomal doxorubicin
  • +5 more
  • Shanghai, China
    Shanghai Pudong Hospital
Dec 11, 2022

Relapsed/Refractory Large B Cell Lymphoma Trial (biological, drug, genetic)

Not yet recruiting
  • Relapsed/Refractory Large B Cell Lymphoma
  • ALLO-647
  • +3 more
  • (no location specified)
Feb 6, 2023

Lymphoma, Large B-Cell, Diffuse Trial in Worldwide (lenalidomide, Placebo, Rituximab)

Completed
  • Lymphoma, Large B-Cell, Diffuse
  • Fayetteville, Arkansas
  • +431 more
Nov 17, 2022

Hyperspectral Imaging Technique in CTX Treatment of IMN

Not yet recruiting
  • Hyperspectral Imaging
  • +2 more
  • Microscopic hyperspectral imaging system
  • (no location specified)
Apr 29, 2023